Found: 4
Select item for more details and to access through your institution.
Phase 1 randomized trials to assess safety, pharmacokinetics, and vaginal bleeding associated with use of extended duration dapivirine and levonorgestrel vaginal rings.
- Published in:
- PLoS ONE, 2024, v. 19, n. 6, p. 1, doi. 10.1371/journal.pone.0304552
- By:
- Publication type:
- Article
Characterization of Viruses in Phase 3 and Phase 3b Trials (the Ring Study and the Dapivirine Ring Extended Access and Monitoring Trial) of the Dapivirine Vaginal Ring for Human Immunodeficiency Virus Type 1 Infection Risk Reduction.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 6, p. 996, doi. 10.1093/cid/ciac875
- By:
- Publication type:
- Article
Clinical Presentation, Treatment Response, and Virology Outcomes of Women Who Seroconverted in the Dapivirine Vaginal Ring Trials—The Ring Study and DREAM.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 3, p. 389, doi. 10.1093/cid/ciac804
- By:
- Publication type:
- Article
Phase 1 pharmacokinetics and safety study of extended duration dapivirine vaginal rings in the United States.
- Published in:
- Journal of the International AIDS Society, 2021, v. 24, n. 6, p. 1, doi. 10.1002/jia2.25747
- By:
- Publication type:
- Article